5 years ago

Axis Spine Secures £830,000 Funding for US Expansion

  • Axis Spine, a UK-based spinal implant company, has raised £830,000 in funding led by Mercia with participation from two private investors

  • The company intends to use the funds to launch trials of its product in the US and start early commercialization, aiming to enter the £7 billion US spinal implant market

  • The company expects to secure clearance from the US Food and Drug Administration (FDA) next month.

      • ProblemHealthcare

      "Spinal implants are often rigid and can cause pain and discomfort for patients."

      Solution

      "Axis Spine has developed a new type of spinal implant that is more flexible and less likely to cause pain. They are seeking FDA clearance in the US and are looking to launch trials."

      Covered on